None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who requires partial or segmental resection of trachea for the treatment of trachea diseases such as congenital tracheomalacia and traumatic tracheal stenosis, or invading the trachea due to the progression of thyroid cancer. Patients who are expected to have functional disorders such as respiratory failure or permanent tracheostomy due to the impossibility of reconstruction of the trachea defect.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women 2. Those who have had surgery around the thyroid gland or airway before screening 3. Patients with residual inflammation in the tissues around the thyroid gland or airways at the time of screening 4. Patients with systemic inflammatory disease at the time of screening 5. People at high risk of general anesthesia due to liver disease, kidney disease, or heart disease 6. Patients with sepsis at the time of screening 7. Patients with a predisposition to bleeding at the time of screening 8. Those who have had radiation treatment to the head/neck area before screening 9. Those who have used other clinical trial drugs and clinical trial medical devices within 3 months before screening 10. Patients with a history of cell therapy 11. Patients with malignant tumors other than thyroid cancer 12. Persons judged by other investigators as inappropriate to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Flexible laryngoscopy | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Seoul St. Mary's Hospital